Roderick Todd Bunch
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment
Papers in
-
- Carcinogens and Genotoxicity Assessment 7
- Oncology 4
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Alan R. Eastman (2 shared papers)Kent B. Thudium (2 shared papers)Mark Selby (2 shared papers)Alan J. Korman (2 shared papers)Carl L. Alden (8 shared papers)Yi Ming Wu (1 shared paper)Michelle R. Kuhné (1 shared paper)Changyu Wang (1 shared paper)
- Journals
- Toxicologic Pathology (8 papers)Cancer Chemotherapy and Pharmacology (2 papers)Toxicology and Applied Pharmacology (2 papers)Biochemical Pharmacology (2 papers)Cancer Immunology Research (2 papers)
- Partner nations
- United States
In The Last Decade
Roderick Todd Bunch
31 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 58
- Oncology 435
- Cancer Research 79
- Small Animals 47
- Pharmacology 70
- Molecular Biology 192
Countries citing papers authored by Roderick Todd Bunch
This map shows the geographic impact of Roderick Todd Bunch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roderick Todd Bunch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roderick Todd Bunch more than expected).
Fields of papers citing papers by Roderick Todd Bunch
This network shows the impact of papers produced by Roderick Todd Bunch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roderick Todd Bunch. The network helps show where Roderick Todd Bunch may publish in the future.
Co-authors
The 25 scholars most cited alongside Roderick Todd Bunch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 534 | |
| 2 | Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor. | 1996 | 201 |
| 3 | 1998 | 177 | |
| 4 | The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells. | 1994 | 129 |
| 5 | 2022 | 71 | |
| 6 | 2004 | 48 | |
| 7 | 2003 | 41 | |
| 8 | 2001 | 39 | |
| 9 | 1999 | 27 | |
| 10 | 1995 | 22 | |
| 11 | 1994 | 19 | |
| 12 | 2005 | 19 | |
| 13 | 2001 | 18 | |
| 14 | Dissociation between bulk damage to DNA and the antiproliferative activity of teniposide (VM-26) in the MCF-7 breast tumor cell line: evidence for induction of gene-specific damage and alterations in gene expression. | 1993 | 17 |
| 15 | 1998 | 14 | |
| 16 | 2017 | 14 | |
| 17 | A combined alkaline unwinding/Southern blotting assay for measuring low levels of cellular DNA breakage within specific genomic regions. | 1992 | 13 |
| 18 | 2016 | 12 | |
| 19 | 2015 | 11 | |
| 20 | 1999 | 10 |
About Roderick Todd Bunch
Roderick Todd Bunch is a scholar working on Cancer Research, Oncology, Molecular Biology, Pharmacology and Biochemistry, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (7 papers), Cancer Immunotherapy and Biomarkers (3 papers), DNA Repair Mechanisms (2 papers), Inflammatory mediators and NSAID effects (2 papers), Cancer therapeutics and mechanisms (2 papers), Mitochondrial Function and Pathology (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Antioxidant Activity and Oxidative Stress (1 paper). The work is most often cited by research in Oncology (435 citations), Cancer Research (79 citations), Small Animals (47 citations), Pharmacology (70 citations) and Molecular Biology (192 citations). Roderick Todd Bunch has collaborated with scholars based in United States. Frequent co-authors include Alan R. Eastman, Kent B. Thudium, Mark Selby, Alan J. Korman, Carl L. Alden, Yi Ming Wu, Michelle R. Kuhné, Changyu Wang, Sujata Singh and Minhua Han. Their work appears in journals such as Toxicologic Pathology, Cancer Chemotherapy and Pharmacology, Toxicology and Applied Pharmacology, Biochemical Pharmacology and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.